Department of Hepatobiliary Oncology, Cancer Center, Sun Yat-sen University, 651 Dongfeng Road East, Guangzhou, 510060, People's Republic of China.
Med Oncol. 2013 Dec;30(4):696. doi: 10.1007/s12032-013-0696-3. Epub 2013 Aug 22.
The long-term outcome and prognostic factors after curative in patients with single hepatocellular carcinoma (HCC) without macrovascular invasion are still unclear. The objective of this study is to evaluate the effect of curative resection on survival and analyze the prognostic clinicopathologic factors, especially the presence of microvascular invasion (MVI), in these patients. Two hundred and sixty consecutive patients with single HCC without macrovascular invasion who underwent curative resection from December 2004 to December 2007 were retrospectively reviewed in this study. Survival rates were calculated by using the Kaplan-Meier method. Univariate and multivariate analyses of 14 clinicopathologic factors were performed to determine the significant prognostic factors. No patient died within 1 month after the operation. The 1-, 3-, and 5-year overall survival rates after curative resection were 96.54, 83.46, and 74.01%, respectively. Multivariate analysis revealed that only the presence of MVI was an independent negative prognostic factor affecting overall survival. The 1-, 3-, and 5-year disease-free survival rates were 79.62, 62.69, and 56.01%, respectively. The presence of MVI was the only independent unfavorable prognostic factor for disease-free survival. According to our analysis, patients with single HCC without macrovascular invasion after curative resection can be expected to have considerable long-term survival. The presence of MVI was an independent negative prognostic factor for both overall survival and disease-free survival. To improve the prognosis, these patients should be followed up more carefully and might be good candidates for adjuvant therapy.
在没有大血管侵犯的单发性肝细胞癌 (HCC) 患者中,根治性切除术后的长期预后和预测因素仍不清楚。本研究的目的是评估根治性切除对生存的影响,并分析这些患者的临床病理预后因素,特别是微血管侵犯 (MVI) 的存在。本研究回顾性分析了 2004 年 12 月至 2007 年 12 月期间接受根治性切除的 260 例无大血管侵犯的单发性 HCC 患者。采用 Kaplan-Meier 法计算生存率。对 14 项临床病理因素进行单因素和多因素分析,确定显著的预后因素。术后 1 个月内无患者死亡。根治性切除术后 1、3 和 5 年总生存率分别为 96.54%、83.46%和 74.01%。多因素分析显示,只有 MVI 的存在是影响总生存的独立负预后因素。无复发生存率分别为 79.62%、62.69%和 56.01%。MVI 的存在是无复发生存的唯一独立不良预后因素。根据我们的分析,根治性切除术后无大血管侵犯的单发性 HCC 患者有望获得相当长的长期生存。MVI 的存在是总生存和无复发生存的独立负预后因素。为了改善预后,这些患者应更密切地随访,并且可能是辅助治疗的良好候选者。